Because aggressive and therapeutic resistant prostate cancer cells often express stem cell-associated genes, we tested the possible directive effects of KRT13 in driving prostate cancer local growth, invasion and distant metastasis. This evidence concerns the gene KRT13 and prostate carcinoma.